Ignite Creation Date:
2025-12-24 @ 10:55 PM
Ignite Modification Date:
2026-06-14 @ 9:14 AM
Study NCT ID:
NCT05872269
Status:
RECRUITING
Last Update Posted:
2024-02-07
First Post:
2023-05-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Safety and Effectiveness of Saroglitazar 4 mg in Patients With NAFLD With Comorbidities
Sponsor:
Zydus Lifesciences Limited
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SARO.21.003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None